Amedisys, Inc. (NASDAQ:AMED) Stock Position Cut by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 7.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,270 shares of the health services provider’s stock after selling 484 shares during the period. Victory Capital Management Inc.’s holdings in Amedisys were worth $605,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Alpine Associates Management Inc. increased its stake in shares of Amedisys by 0.9% during the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock valued at $117,586,000 after acquiring an additional 11,000 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after buying an additional 19,660 shares in the last quarter. Calamos Advisors LLC lifted its holdings in shares of Amedisys by 11.6% in the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after buying an additional 41,220 shares during the period. Highbridge Capital Management LLC boosted its stake in Amedisys by 34.7% during the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after buying an additional 83,200 shares in the last quarter. Finally, SG Americas Securities LLC grew its holdings in Amedisys by 413.4% during the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after acquiring an additional 158,398 shares during the period. 94.36% of the stock is currently owned by institutional investors.

Amedisys Price Performance

Shares of Amedisys stock opened at $91.23 on Friday. Amedisys, Inc. has a 52 week low of $88.81 and a 52 week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The company’s 50-day moving average price is $94.98 and its two-hundred day moving average price is $95.68. The stock has a market cap of $2.99 billion, a PE ratio of 36.20, a price-to-earnings-growth ratio of 1.91 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.98 earnings per share. As a group, sell-side analysts anticipate that Amedisys, Inc. will post 4.55 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.